Key Points
- Clinical genomics: Agilent launched CE-IVD-labeled TapeStationDx systems for standardized DNA and RNA quality control before next-generation sequencing.
- Regulatory watch: An FDA advisory panel reviewed GRAIL’s blood-based Galleri multi-cancer screening test, a consequential step for sequencing-based diagnostics.
- Lab operations: Eppendorf added a high-capacity centrifuge with traceable records, laboratory-system connectivity, and lower-impact refrigeration.
- Research infrastructure: New projects advanced governed lab AI, fusion-material testing, and over-the-air measurement for emerging 6G systems.
Lab Lowdown is LabPress’s quick Friday briefing on the developments shaping laboratory work. This edition covers original announcements published from Sept. 18 through Sept. 25, 2026, with research checked at 8 a.m. ET on Sept. 25. The week brought consequential movement in clinical diagnostics, instrument design, laboratory informatics, fusion research, and advanced engineering test.
Agilent Brings TapeStation Quality Control Into Clinical NGS
Agilent launched its 4150 and 4200 TapeStationDx systems, along with TapeStationDx software, on Sept. 21. The company says the CE-IVD-labeled platform is designed to standardize and document DNA and RNA quality control before clinical next-generation sequencing. The lower-throughput system handles one to 16 samples, while the 4200 scales to 96. Software features include audit trails, electronic signatures, reporting, and data export.
The release matters because poor input quality can force repeat work and slow clinical reporting, while regulated laboratories need traceable decisions about whether a sample is suitable for sequencing. Availability and regulatory status vary by market, and Agilent’s performance statements remain company claims that laboratories should confirm during validation. Read Agilent’s Sept. 21 announcement.
FDA Panel Reviews a Blood Test for Multi-Cancer Screening
The FDA’s Molecular and Clinical Genetics Panel met Sept. 23 to review GRAIL’s premarket approval application for Galleri. The prescription-only test uses next-generation sequencing to identify cancer-associated methylation patterns in cell-free DNA from a blood sample. It is intended for adults 50 and older and is designed to predict where a detected signal may have originated before follow-up diagnostic work.
FDA advisory recommendations are nonbinding, but the review is a major test of the evidence standards that could shape future multi-cancer early detection assays. Clinical laboratories should watch how regulators weigh sensitivity across cancer types, false-positive findings, confirmatory pathways, and the difference between screening and diagnosis. See the FDA meeting record and materials.
Eppendorf Updates High-Capacity Centrifugation
Eppendorf introduced the refrigerated SpinPro 8 R floor-standing centrifuge on Sept. 22. The company lists capacity up to 6 liters, compatibility with more than 30 existing rotors, two new rotor options, traceable run documentation, and connections to LIMS and electronic laboratory notebooks through standard protocols. Its R744 carbon dioxide refrigerant has a stated global warming potential of 1.
For bioprocessing, pharmaceutical, and shared academic facilities, the practical story is consolidation. A broader mix of vessels and workflows on one platform can simplify training and utilization, while AuditSafe Mode and digital records may help with review in regulated environments. Laboratories should still qualify the system against their own protocols and compliance plan. Compare selection factors in LabPress’s laboratory centrifuge buyer’s guide, and read Eppendorf’s release.
Scitara Expands Its Lab Intelligence Strategy
Scitara said Sept. 21 that it is expanding from laboratory connectivity into a broader lab intelligence strategy. The roadmap adds laboratory-focused AI applications and agentic orchestration to the company’s instrument and data-integration foundation. Scitara also appointed former AWS and TetraScience executive Mike Tarselli as chief strategy officer.
This is a strategic announcement rather than an independent product-validation report. Its significance lies in the sequence of operations: governed identifiers, permissions, provenance, and connected instruments must support any reliable AI-driven workflow. Regulated buyers should ask which functions are available today, where human approvals enter the process, and what audit evidence is retained. Read LabPress’s coverage and the original company release.
Missouri Reactor Joins ITER Materials Testing
The University of Missouri Research Reactor announced a partnership with Princeton Plasma Physics Laboratory on Sept. 21 to support the international ITER fusion project. MURR researchers will irradiate graphite from a PPPL diagnostic instrument that is designed to measure the temperature of charged particles inside ITER’s plasma. The testing will assess how the material degrades under radiation.
This work illustrates how specialized laboratories underpin large science projects long before a full system operates. MURR says its neutron output and operating flexibility occupy a useful middle ground between commercial reactors and smaller university devices, making it suited to the planned exposure. The laboratory’s suitability and fusion potential are institutional statements, while the immediate deliverable is a defined materials-qualification study. Read the University of Missouri announcement.
UC Berkeley and Keysight Target Faster 6G Measurements
Keysight announced a Sept. 24 collaboration with the Berkeley Wireless Research Center to study new over-the-air measurement methods for emerging 6G devices and systems. The work, led by UC Berkeley assistant professor Aditya Muppala, focuses on upper-midband spectrum, or FR3, and the challenge of characterizing increasingly complex antenna and beamforming systems across three-dimensional space.
The research is preliminary, and claims about faster or more flexible measurements have yet to be demonstrated in an independent published result. The laboratory problem is immediate, however. Advanced wireless, radar, and non-terrestrial-network devices demand test methods that can keep pace with more bands and intricate antenna architectures. Read Keysight’s Sept. 24 announcement.
Keep up with LabPress: Visit the Lab Lowdown archive for each week’s rapid laboratory news briefing.
Keep Exploring
Related Reading
Connecting Laboratory Instruments to LIMS and ELN
A practical guide to connecting laboratory instruments with LIMS and ELN systems, covering interfaces, metadata, identity, error handling, cybersecurity,…Read Article
Best Laboratory Centrifuges for Clinical, Research, and Bioprocess Work
An evidence-based guide to laboratory centrifuges for clinical, research, and bioprocess work, with vendor rankings, specialist shortlists, and configuration…Read Article
Leave a Reply